Treace Medical Concepts (TMCI) EBITDA Margin Growth (1y) (2021 - 2026)
Treace Medical Concepts (TMCI) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | 241.00 |
| 10 | Treace Medical Concepts | 262.63 Mn | 210.78 Mn | 37.41 Mn | -673.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -673.00 |
| Dec 31, 2025 | -918.00 |
| Sep 30, 2025 | 235.00 |
| Jun 30, 2025 | 1,228.00 |
| Mar 31, 2025 | 747.00 |
| Dec 31, 2024 | 1,060.00 |
| Sep 30, 2024 | 1,015.00 |
| Jun 30, 2024 | -1,699.00 |
| Mar 31, 2024 | -447.00 |
| Dec 31, 2023 | -387.00 |
| Sep 30, 2023 | -948.00 |
| Jun 30, 2023 | 871.00 |
| Mar 31, 2023 | -478.00 |
| Dec 31, 2022 | 971.00 |
| Sep 30, 2022 | -898.00 |
| Jun 30, 2022 | -2,021.00 |
| Mar 31, 2022 | -2,038.00 |
| Dec 31, 2021 | -3,182.00 |
| Sep 30, 2021 | -2,481.00 |
| Jun 30, 2021 | 0.00 |